Indication
Crimean-Congo hemorrhagic fever
1 clinical trial
2 products
Clinical trial
UMIT-1 Trial: Favipiravir & Ribavirin Phase IB A Randomised Phase Ib Study to Determine the Phase II Dose and to Evaluate the Safety and Efficacy of Intravenous (IV) Favipiravir & RibavirinStatus: Recruiting, Estimated PCD: 2023-09-30
Product
FavipiravirProduct
Ribavirin